Analysis in brief: The rollout of the first vaccine approved to combat malaria will positively impact economic and societal change in Africa and end family tragedies for millions. While drug trials herald a medical breakthrough, health officials have been focused on results and not publicity.
The cost of malaria
For centuries, the development of Africa, particularly the central and southern regions, has been hampered by the prevalence of malaria, a disease more virulent in Africa than on any other continent. Africa is home to a particular type of mosquito, the Anopheles gambiae, which is extremely efficient at transmitting the parasite Plasmodium falciparum (the species that is most responsible for severe malaria and death) through skin bites to humans.
Read more